Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market Report 2026

Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market Overview

• Artificial Intelligence Or Machine Learning (AI/ML) Medical Device market size has reached to $8.11 billion in 2025 • Expected to grow to $26.46 billion in 2030 at a compound annual growth rate (CAGR) of 26.8% • Growth Driver: Strategic Investments Driving Growth In The Future Of Artificial Intelligence Or Machine Learning Medical Devices • Market Trend: Navigating The Future Of Ai/Ml Medical Devices Through Tech Breakthroughs • North America was the largest region in 2025.

The key promising market opportunities in the artificial intelligence or machine learning (ai/ml) medical device market include: • Radiology (Segmentation By Clinical Area) → Expected gain of $12549.93 Million • Software-As-A-Medical Device (SaMD) (Segmentation By Product) → Expected gain of $10332.01 Million • Pharmaceuticals And Biotechnology Companies (Segmentation By End-User Industry) → Expected gain of $6283.85 Million

What Is Covered Under Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market?

An artificial intelligence or machine learning (AI/ML) medical device is a medical device that incorporates artificial intelligence and machine learning technologies to analyse medical data, make predictions, support diagnoses, or assist healthcare professionals in decision-making. Artificial intelligence, or machine learning, has several beneficial applications in the medical device sector, including handling data, remote surgical procedures, diagnostic and operational assistance, and clinical trials. The main products included in artificial intelligence machine learning medical devices are systems or hardware and software-as-a medical device. Hardware represents the actual components of a system or the ways it can store and execute the written instructions included in the application's software. The various clinical areas include radiology, cardiology, haematology, and others, which are used by several end-users such as hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, healthcare payers, and others.

What Is The Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market Growth Forecast?

The artificial intelligence or machine learning (ai/ml) medical device market size is expected to see exponential growth in the next few years. It will grow to $26.46 billion in 2030 at a compound annual growth rate (CAGR) of 26.8%. The growth in the forecast period can be attributed to rising adoption of precision medicine, expansion of telehealth services, regulatory approvals for AI medical devices, demand for early disease detection, growth of value-based healthcare models. Major trends in the forecast period include ai-powered diagnostic imaging, clinical decision support systems, remote patient monitoring devices, predictive healthcare analytics, robotic-assisted medical procedures.

What Is The Driver Of The Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market?

Investments in healthcare AI are expected to propel the growth of the artificial intelligence or machine learning medical device market going forward. Healthcare AI (Artificial Intelligence) refers to applying AI technologies in the healthcare industry to improve healthcare delivery, diagnosis, treatment, and overall patient care. Investments in AI healthcare are driven by the potential for AI and ML technologies to revolutionise healthcare delivery, improve patient outcomes, and enhance operational efficiency. For instance, in March 2023, according to the Department of Health and Social Care, a UK-based government department, over 300,000 patients benefited from $147.2 million (£123 million) invested in 86 AI technologies over three rounds of awards. Additionally, Mendelian, a UK-based digital health startup, has been awarded $1.7 million (£1.4 million) to support an AI system that identifies patients with undiagnosed rare diseases. Further, Medtronic, a US-based medical device company, was awarded $3.18 million (£2.5 million) to further develop an AI-based medical device called GI Genius. Therefore, investments in healthcare AI drive the growth of the artificial intelligence and machine learning medical device market.

How Will The Drivers Impact Growth In The Global Artificial Intelligence Or Machine Learning (AIML) Medical Device Market?

• Demand for Improved Diagnostic Accuracy (Medium) – During the forecast period, the growing demand for improved diagnostic accuracy is expected to be a key driver propelling growth in the ai/ml medical device market. as healthcare providers seek more precise, timely, and personalized diagnostic solutions, and as patient volumes increase across both developed and emerging healthcare systems, the adoption of ai- and machine learning-enabled medical devices is projected to rise steadily, leading to heightened demand for ai-powered imaging, predictive analytics, decision support systems, and automated diagnostic tools. a focus on improved diagnostic accuracy drives the development and deployment of ai/ml algorithms, advanced sensor integration, and software-based medical devices across radiology, cardiology, pathology, and other clinical domains, fueling investment by medical device manufacturers, healthcare institutions, and technology providers in research, product development, and clinical validation. as a result, ai/ml medical device companies are increasingly expanding technical capabilities, enhancing regulatory compliance, and strengthening clinical support and integration services to meet rising demand for accurate, efficient, and scalable diagnostic solutions. as a result, the growing demand for improved diagnostic accuracy growth contributing to a 1.5% annual growth in the market. • Rising Prevalence of Chronic Diseases (Medium) – During the forecast period, the rising prevalence of chronic diseases globally is expected to be a key driver propelling growth in the ai/ml medical device market. as aging populations expand, lifestyle-related health conditions increase, and the burden of chronic diseases such as cardiovascular disorders, diabetes, respiratory illnesses, and cancer continues to grow across both developed and emerging economies, the demand for advanced diagnostic, monitoring, and therapeutic solutions is projected to increase steadily, leading to heightened adoption of ai- and ml-enabled medical devices across hospitals, clinics, and home care settings. a growing chronic disease burden increases the need for continuous patient monitoring, early diagnosis, predictive analytics, and personalized treatment plans, driving sustained demand for ai-powered imaging systems, wearable sensors, remote monitoring platforms, and software-based clinical decision support tools. as a result, ai/ml medical device developers, healthcare technology providers, and clinical service partners are increasingly investing in product innovation, expanding deployment infrastructure, and enhancing integration capabilities to support rising clinical demand and sustain long-term growth in the global ai/ml medical device market. consequently, the rising prevalence of chronic diseases growth contributing to a 1.3% annual growth in the market. • Increasing Digital Transformation in Healthcare (Low) – During the forecast period, the increasing adoption of digital transformation initiatives in healthcare is expected to be a key driver propelling growth in the ai/ml medical device market. as hospitals, clinics, and diagnostic centers modernize their infrastructure, healthcare providers increasingly integrate electronic health records (ehrs), cloud computing, telemedicine platforms, and data analytics systems, leading to greater demand for ai- and ml-powered diagnostic and therapeutic devices. a growing emphasis on data-driven decision-making and personalized medicine increases the deployment of ai-enabled imaging systems, predictive analytics tools, robotic-assisted surgical devices, and software-based medical solutions, driving sustained adoption across clinical, outpatient, and hospital settings. as a result, ai/ml medical device manufacturers, technology integrators, and service providers are increasingly expanding r&d investments, strengthening clinical partnerships, and enhancing software and hardware deployment capabilities to support rising digital transformation initiatives and sustain long-term growth in the global ai/ml medical device market. therefore, increasing adoption of digital transformation initiatives in healthcare growth contributing to a 1.0% annual growth in the market. • Favorable Government Initiatives Towards AI-enabled Medical Devices (Low) – During the forecast period, favorable government initiatives globally are expected to be a key driver propelling growth in the AI/ML medical device market. As regulatory frameworks evolve, healthcare modernization programs expand, and public funding for digital health and precision medicine increases across both developed and emerging economies, the adoption of AI-enabled medical devices in hospitals, diagnostic centers, and research institutions is projected to rise steadily, leading to heightened deployment of AI/ML-powered imaging, diagnostic, and monitoring solutions. Growing government support accelerates approvals, incentivizes innovation, and encourages integration of AI technologies into clinical workflows, driving sustained demand for AI-assisted radiology systems, robotic surgery platforms, predictive analytics tools, and software-as-a-medical-device (SaMD) solutions. As a result, AI/ML medical device manufacturers, technology developers, and healthcare providers are increasingly investing in research and development, strengthening regulatory compliance teams, and enhancing clinical validation and deployment capabilities to support adoption of AI-enabled devices and sustain long-term growth in the global AI/ML medical device market. The favorable government initiatives towards AI-enabled medical devices growth contribution during the forecast period in 2025 is 0.5%.

How Will The Restraints Impact Growth In The Global Artificial Intelligence Or Machine Learning (AIML) Medical Device Market?

• Data Privacy and Security Concerns (Medium) – During the forecast period, data privacy and security concerns are restricting the growth of the AI/ML medical device market. Persistent risks associated with unauthorized access, cyberattacks, data breaches, and non-compliance with healthcare regulations are placing operational and legal pressures on hospitals, diagnostic centers, and medical device manufacturers, which in turn discourages widespread adoption of AI/ML-enabled solutions. From a clinical and technological perspective, stringent requirements for patient data protection, secure handling of sensitive health records, encryption protocols, and compliance with standards such as HIPAA and GDPR increase the burden on end users and developers to implement robust security frameworks, often at the expense of rapid deployment and innovation. These privacy and cybersecurity challenges, coupled with evolving regulatory scrutiny, complex data governance policies, and limited availability of secure AI/ML infrastructure, intensify operational and legal risks and heighten concerns over patient trust and ethical usage. As a result, AI/ML medical device manufacturers, healthcare providers, and software developers may face constrained adoption rates, more cautious integration strategies, and delayed investments in AI-enabled diagnostic and treatment technologies. Growth affected by the data privacy and security concerns during the forecast period in 2025 is -2.0%. • Integration with Legacy Healthcare IT Systems (Medium) – During the forecast period, integration with legacy healthcare IT systems is restricting the growth of the AI/ML medical device market. Persistent challenges associated with connecting AI/ML-enabled devices to existing electronic health records (EHRs), hospital information systems (HIS), and clinical workflow platforms are placing operational strain on healthcare providers and IT departments, which in turn discourages rapid adoption and full utilization of AI/ML medical technologies. From a commercial and clinical perspective, elevated complexity for system interoperability, data standardization, and compliance with healthcare IT regulations increases pressure on hospitals and clinics to delay AI/ML device deployment, limit functionality integration, and rely on manual data workflows, often at the expense of device performance and predictive accuracy. These integration challenges, coupled with limited IT resources, legacy system constraints, and concerns over cybersecurity and data privacy, intensify operational burdens and heighten the risk of suboptimal clinical outcomes and delayed analytics insights. As a result, AI/ML medical device manufacturers, healthcare IT providers, and clinical institutions may face constrained demand for advanced AI-enabled solutions, more cautious technology upgrade strategies, and delayed investments in predictive, data-driven healthcare tools. Growth affected by the integration with legacy healthcare IT systems during the forecast period in 2025 is -1.0%. • Impact of Trade and Tariff (Low) – During the forecast period, trade restrictions and tariffs are restricting the growth of the AI/ML medical device market. Persistent high import duties, export regulations, and cross-border compliance costs associated with sourcing AI-enabled hardware, software components, and integrated diagnostic devices are placing financial strain on medical device manufacturers, healthcare providers, and technology developers, which in turn discourages global expansion and collaborative deployments. From a commercial and operational perspective, elevated tariffs on AI/ML-enabled imaging systems, diagnostic platforms, and software-as-a-medical-device solutions, including charges for regulatory compliance, customs clearance, and cross-border data handling, increase pressure on end users and manufacturers to limit international shipments, localize production, or defer technology adoption, often at the expense of clinical efficiency and innovation. These trade and tariff dynamics, coupled with fluctuating import/export regulations, restricted market access, and uncertainty in international supply chains, intensify operational burdens and heighten the risk of delayed product launches, reduced market penetration, and limited adoption of advanced AI/ML medical technologies. As a result, AI/ML medical device companies, healthcare institutions, and technology partners may face constrained demand for high-end devices, more cautious investment strategies, and delayed integration of AI/ML-driven diagnostic and treatment solutions. Growth affected by the trade restrictions and tariffs during the forecast period in 2025 is -0.3%.

Key Players In The Global Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market

Major companies operating in the artificial intelligence or machine learning (ai/ml) medical device market are General Electric; Medtronic PLC; Canon Inc.; Nvidia Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Stryker Corporation; RadNet Inc.; ShanghAI United Imaging Healthcare Co. Ltd.; Tempus; DataRobot Inc.; DeepMind Technologies Limited; Paige AI Inc.; Aidoc Medical Ltd.; Butterfly Network Inc.; Aidoc Medical; CellaVision AB; Clarius Mobile Health Corp.; Subtle Medical Inc.; Owkin Inc.; Cleerly Inc.; Behold.ai; Viz.AI Inc.; Arterys Inc.; Caption Health; Enlitic Inc.; Hyperfine Inc.; Nanox AI Ltd.

Global Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market Trends and Insights

Major companies operating in the artificial intelligence (AI) and machine learning (ML) medical device market are focusing on developing advanced technologies such as artificial intelligence (AI)-driven performance insights to enhance surgical precision, optimise clinical workflows, and improve patient outcomes through data-driven decision support. Artificial intelligence (AI)-driven Performance Insights is an advanced analytics system that uses artificial intelligence algorithms to analyse surgical videos and generate actionable insights to improve surgical performance, efficiency, and training. For instance, in April 2024, Medtronic plc, an Ireland-based medical devices company, launched 14 new AI-driven Performance Insights algorithms and Touch Surgery Live Stream technology, designed to enhance laparoscopic and robotic-assisted surgical procedures. These solutions enable AI-based post-operative analysis, delivering detailed insights into surgical techniques, and offer real-time, remote observation for improved surgical education and connectivity, thereby setting a new benchmark in AI-powered surgical performance.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market?

In April 2024, GE HealthCare, a US-based medical technology and digital solutions company, acquired MIM Software for an undisclosed amount. Through this acquisition, GE HealthCare aims to strengthen its AI-powered imaging and workflow capabilities in oncology, urology, neurology, and cardiology by integrating MIM Software’s advanced image-analysis and multi-modality processing technologies. MIM Software is a US-based medical imaging software provider that develops AI and machine learning (ML)-enabled solutions for image analysis, processing, and treatment planning

What Defines the Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market?

The artificial intelligence or machine learning (AI/ML) medical device market consists of revenues earned by entities by providing treatment planning and personalisation, predictive analytics, monitoring, and alert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence or machine learning (AI/ML) medical device market also includes sales of smart wearable health monitors, medical imaging devices, and diagnostic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence Or Machine Learning (AI/ML) Medical Device Market Report 2026?

The artificial intelligence or machine learning (ai/ml) medical device market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence or machine learning (ai/ml) medical device industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.